Scientists have shown that deep brain stimulation during sleep can help people retain new information. The approach could help people with memory problems related to disorders like Alzheimer's.
During sleep, the brain strengthens memories it expects to use in the future. Now, scientists say they've found a way to enhance this process. This research might someday help people with memory loss.
Most first- and second-year medical students don't attend lectures. A student and a professor suggest it's a good time to think a lot about medical education, starting with "flipping the classroom."
Despite its reputation as a lifesaver, for the elderly and medically frail, CPR may cause more harm than good. It's why many doctors opt not to receive it themselves.
Researchers are inching closer to creating human eggs and sperm in the lab that carry a full complement of anyone's DNA. It could revolutionize fertility treatment and raises huge ethical questions.
It's harder for people in some Midwestern and Southern states to get liver transplants than it used to be, highlighting inequities in a system that doctors say has always been unfair.
Opvee is similar to naloxone, the life-saving drug that has been used for decades to quickly counter overdoses of heroin, fentanyl and prescription painkillers.
It can be easy to get your hopes up about exciting new research or alternative approaches to cancer treatment. Here's an insider's guide for figuring out which ones are worth your time.
At least 58,000 childern younger than 5 years old are hospitalized each year with RSV infections. A Pfizer vaccine given to pregnant people could help protect their infants from severe RSV illness.
New weight-loss medications and bariatric surgery have the potential to spare children health and social problems. But some parents think they're sending kids the wrong message about their bodies.
Children who need growth hormone to achieve their full stature are having trouble getting the medicine. A shortage has stretched months longer than expected and could last the rest of the year.
Now that official COVID emergency declarations have ended, how should people evaluate their risk of SARS-CoV-2? That's the subject of our frequently asked questions offering.
A panel of experts voted 8-6 in favor of Food and Drug Administration approval of the first gene therapy for Duchenne muscular dystrophy, a fatal genetic disease.
